AI regulatory strategies: a global public health perspective
Journal of Public Health · 2025
DOI: 10.1093/pubmed/fdaf116 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Public Health, 2025. Verfasst von Nicholas Léger-Riopel. Beteiligte Einrichtung: Law Faculty, Université de Moncton, 18 Antonine-Maillet Avenue, Moncton, NB E1G 6G4, Canada. Hauptthemen laut MEDLINE: Artificial Intelligence, Global Health, Public Health. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Background
Artificial intelligence (AI) has many different potential applications for healthcare system delivery, from imagery testing, triage, to the early detection of infectious patterns in large populations. Scientific literature shows that policies, legislation, and quasi-legislation on the question of AI are rapidly emerging and use one of four main regulatory strategies. Each strategy has limitations and can contribute to the creation of ethical and medico-legal risk, which our research contributes to identify.
Methods
We undertook a double-method literature review, first with a scoping literature review. We identified over 1200 documents from ~71 countries (from every continent), as well as international organizations that had adopted a form of regulatory strategy toward AI. We then proceeded to a narrative literature review where we highlighted both the taxonomy of regulatory strategies in use, and their respective risks and challenges to public health objectives.
Findings
The legal or quasi-legal framework surrounding the use of AI follows one of four possible strategies: trustworthiness, risk-reduction, ethical/principled, or indirect. The vast majority of the documents surveyed reveal that values and principles of public health are not sufficiently, or even explicitly, built-in the normative framework for health applications of AI (Health AI), and creates a wide array of challenges and risks, which our research helps to identify.
Conclusions
This leads to a detrimental situation and leads to two main consequences: the creation of a “regulatory gap” for Health AI, and also a potential mismatch with already existing medico-legal duties of public health actors and health professionals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Law Faculty, Université de Moncton, 18 Antonine-Maillet Avenue, Moncton, NB E1G 6G4, Canada.
- Faculty of Medicine, Sherbrooke University, 2500 Boulevard de l'Université, Sherbrooke, QC J1N 3C6, Canada.
Zitieren
APA
Léger-Riopel, N. (2025). AI regulatory strategies: a global public health perspective. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaf116
Vancouver
Léger-Riopel N. AI regulatory strategies: a global public health perspective. Journal of Public Health. 2025. doi:10.1093/pubmed/fdaf116
BibTeX
@article{LgerRiopel2025,
author = {Léger-Riopel, Nicholas},
title = {AI regulatory strategies: a global public health perspective},
journal = {Journal of Public Health},
year = {2025},
doi = {10.1093/pubmed/fdaf116}
}
EUVIMED